PLUR

Pluri Inc.
CAPPED RATING

Pluri Inc. (PLUR) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Momentum (D). The rating has held at C for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
B-
Factor Score 2.9 / 5.0
Growth
D
Factor Score 1.5 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
D
Factor Score 1.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -0.6
EV / EBITDA -1.9
Rev Growth YoY -15.8%
Gross Margin 44.6%
Price Return 3M -34.4%
Price Return 12M -76.4%
Catalyst Signal 0.00
Market Cap $14.2M
TTM Revenue $1.0M
Price / Sales 14.0
ROE N/A

Historical Factor Score Progression

Held C for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (2.9) D (1.5) B- (3.1) D (1.2) C+ (2.6) C (2.3)
2026-11-07 B- (2.9) D (1.5) B- (3.1) D (1.2) C+ (2.7) C (2.3)
2026-10-31 B- (2.9) D (1.4) B- (3.0) D (1.4) C+ (2.7) C (2.3)
2026-10-24 B- (3.0) D (1.4) B- (3.0) D- (1.0) C+ (2.6) C (2.2)
2026-10-17 B- (3.0) D (1.4) B- (3.0) D- (0.8) C+ (2.6) C (2.2)
Page 1 of 4